TTDS00086	UniProt ID	P35367
TTDS00086	Name	Histamine H1 receptor
TTDS00086	Type of target	Successful target
TTDS00086	Synonyms	H1 Histamine receptor
TTDS00086	Synonyms	Histamine receptor 1
TTDS00086	Disease	Acute lymphoblastic leukaemia (therapy-refractory)
TTDS00086	Disease	Allergic diseases
TTDS00086	Disease	Allergic rhinitis, unspecified
TTDS00086	Disease	Anxiety disorder, unspecified
TTDS00086	Disease	Chronic rhinitis
TTDS00086	Disease	Chronic urticaria
TTDS00086	Disease	Epidermal hyperplasia
TTDS00086	Disease	Epilepsy
TTDS00086	Disease	Hypotension
TTDS00086	Disease	Intimal hyperplasia
TTDS00086	Disease	Ischemia
TTDS00086	Disease	Motion sickness
TTDS00086	Disease	Nausea and vomiting
TTDS00086	Disease	Seasonal allergic rhinitis
TTDS00086	Disease	Systemic arterial vasodilation
TTDS00086	Function	In peripheral tissues, the h1 subclass of histamine receptors mediates the contraction of smooth muscles, increase in capillary permeability due to contraction of terminal venules, and catecholamine release from adrenal medulla, as well as mediating neuro.
TTDS00086	Sequence	MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
TTDS00086	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00086	Pathway	Calcium signaling pathway
TTDS00086	Pathway	Neuroactive ligand-receptor interaction
TTDS00086	Related US Patent	6,506,756
TTDS00086	Related US Patent	6,509,353
TTDS00086	Related US Patent	6,518,287
TTDS00086	Related US Patent	6,525,070
TTDS00086	Related US Patent	6,528,522
TTDS00086	Related US Patent	6,605,302
TTDS00086	Related US Patent	6,613,357
TTDS00086	Related US Patent	6,649,602
TTDS00086	QSAR Model	TTDS00086
TTDS00086	Drug(s)	Loratadine	DAP000101	Allergies	Approved
TTDS00086	Drug(s)	Terfenadine	DAP000102	Allergies	Approved
TTDS00086	Drug(s)	Cyproheptadine	DAP000103	Allergies	Approved
TTDS00086	Drug(s)	Doxepin	DAP000177	Depression	Approved
TTDS00086	Drug(s)	Clemastine	DAP000322	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Cetirizine	DAP000323	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Hydroxyzine	DAP000324	Anxiety disorder	Approved
TTDS00086	Drug(s)	Cinnarizine	DAP000325	Vertigo/meniere's disease	Approved
TTDS00086	Drug(s)	Astemizole	DAP000326	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Propiomazine	DAP000327	Insomnia	Approved
TTDS00086	Drug(s)	Tripelennamine	DAP000328	Asthma	Approved
TTDS00086	Drug(s)	Ketotifen	DAP000329	Allergic conjunctivitis	Approved
TTDS00086	Drug(s)	Fexofenadine	DAP000330	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Desloratadine	DAP000331	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Azelastine	DAP000332	Allergic conjunctivitis	Approved
TTDS00086	Drug(s)	Dimenhydrinate	DAP000333	Nausea and vomiting	Approved
TTDS00086	Drug(s)	Promethazine	DAP000334	Allergic disorders, itching, nausea and vomiting	Approved
TTDS00086	Drug(s)	Levocabastine	DAP000335	Allergic conjunctivitis	Approved
TTDS00086	Drug(s)	Chlorpheniramine	DAP000336	Allergic rhinitis and uriticaria	Approved
TTDS00086	Drug(s)	Cyclizine	DAP000337	Nausea and vomiting	Approved
TTDS00086	Drug(s)	Diphenhydramine	DAP000490	Vertigo/Meniere's disease	Approved
TTDS00086	Drug(s)	Doxylamine	DAP000859	Anxiety and morning sickness	Approved
TTDS00086	Drug(s)	Bepotastine	DAP001061	Allergic rhinitis and uriticaria/puritus	Approved
TTDS00086	Drug(s)	Olopatadine	DAP001062	Allergic conjunctivitis	Approved
TTDS00086	Drug(s)	Olopatadine	DAP001062	Ocular allergy	Phase III
TTDS00086	Drug(s)	Pheniramine	DAP001063	Hay fever	Approved
TTDS00086	Drug(s)	Pemirolast	DAP001064	Allergic conjunctivitis	Approved
TTDS00086	Drug(s)	Triprolidine	DAP001065	Hay fever	Approved
TTDS00086	Drug(s)	Brompheniramine	DAP001066	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Emedastine	DAP001067	Allergic conjunctivitis	Approved
TTDS00086	Drug(s)	Dexbrompheniramine	DAP001068	Hay fever	Approved
TTDS00086	Drug(s)	Carbinoxamine	DAP001069	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Methdilazine	DAP001070	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Diphenylpyraline	DAP001071	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Bromodiphenhydramine	DAP001072	Hay fever	Approved
TTDS00086	Drug(s)	Phenindamine	DAP001073	Common Cold and Allergies	Approved
TTDS00086	Drug(s)	Epinastine	DAP001074	Allergic conjunctivitis	Approved
TTDS00086	Drug(s)	Aceprometazine	DAP001075	Sleep disorders	Approved
TTDS00086	Drug(s)	Buclizine	DAP001076	Nausea and vomiting	Approved
TTDS00086	Drug(s)	Trimeprazine	DAP001077	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Mequitazine	DAP001078	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Azatadine	DAP001079	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Chlophedianol	DAP001080	Anesthetic	Approved
TTDS00086	Drug(s)	(S)-(+)-Dimethindene maleate	DAP001340	Pruritus	Approved
TTDS00086	Drug(s)	Acrivastine	DAP001343	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Antazoline	DAP001347	Nasal congestion	Approved
TTDS00086	Drug(s)	Antazoline hydrochloride	DAP001365	Ocular allergies	Approved
TTDS00086	Drug(s)	Dimethindene	DAP001366	Respiratory allergies	Approved
TTDS00086	Drug(s)	Antazoline phosphate	DAP001373	Ocular allergies	Approved
TTDS00086	Drug(s)	Dimethindene maleate	DAP001378	Respiratory allergies	Approved
TTDS00086	Drug(s)	Ergotidine	DAP001379	Respiratory allergies	Approved
TTDS00086	Drug(s)	Levocetirizine dihydrochloride	DAP001397	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Mepyramine	DAP001399	Allergies	Approved
TTDS00086	Drug(s)	Mepyramine maleate	DAP001400	Allergies	Approved
TTDS00086	Drug(s)	Mizolastine	DAP001403	Allergic rhinitis	Approved
TTDS00086	Drug(s)	Oxatomide	DAP001414	Hay fever	Approved
TTDS00086	Drug(s)	Tranilast	DAP001531	Ocular allergy	Marketed
TTDS00086	Drug(s)	Bepotastine besilate	DCL000719	Allergic conjunctivitis	Approved
TTDS00086	Drug(s)	Bepotastine besilate	DCL000719	Ocular allergy	Phase III
TTDS00086	Drug(s)	Alcaftadine	DAP001553	Allergic conjunctivitis	Approved
TTDS00086	Inhibitor	Doxepin	DAP000177
TTDS00086	Antagonist	Loratadine	DAP000101
TTDS00086	Antagonist	Terfenadine	DAP000102
TTDS00086	Antagonist	Cyproheptadine	DAP000103
TTDS00086	Antagonist	Clemastine	DAP000322
TTDS00086	Antagonist	Cetirizine	DAP000323
TTDS00086	Antagonist	Hydroxyzine	DAP000324
TTDS00086	Antagonist	Cinnarizine	DAP000325
TTDS00086	Antagonist	Astemizole	DAP000326
TTDS00086	Antagonist	Propiomazine	DAP000327
TTDS00086	Antagonist	Tripelennamine	DAP000328
TTDS00086	Antagonist	Ketotifen	DAP000329
TTDS00086	Antagonist	Fexofenadine	DAP000330
TTDS00086	Antagonist	Desloratadine	DAP000331
TTDS00086	Antagonist	Azelastine	DAP000332
TTDS00086	Antagonist	Dimenhydrinate	DAP000333
TTDS00086	Antagonist	Promethazine	DAP000334
TTDS00086	Antagonist	Levocabastine	DAP000335
TTDS00086	Antagonist	Chlorpheniramine	DAP000336
TTDS00086	Antagonist	Cyclizine	DAP000337
TTDS00086	Antagonist	Diphenhydramine	DAP000490
TTDS00086	Antagonist	Doxylamine	DAP000859
TTDS00086	Antagonist	Bepotastine	DAP001061
TTDS00086	Antagonist	Olopatadine	DAP001062
TTDS00086	Antagonist	Olopatadine	DAP001062
TTDS00086	Antagonist	Pheniramine	DAP001063
TTDS00086	Antagonist	Pemirolast	DAP001064
TTDS00086	Antagonist	Triprolidine	DAP001065
TTDS00086	Antagonist	Brompheniramine	DAP001066
TTDS00086	Antagonist	Emedastine	DAP001067
TTDS00086	Antagonist	Dexbrompheniramine	DAP001068
TTDS00086	Antagonist	Carbinoxamine	DAP001069
TTDS00086	Antagonist	Methdilazine	DAP001070
TTDS00086	Antagonist	Diphenylpyraline	DAP001071
TTDS00086	Antagonist	Bromodiphenhydramine	DAP001072
TTDS00086	Antagonist	Phenindamine	DAP001073
TTDS00086	Antagonist	Epinastine	DAP001074
TTDS00086	Antagonist	Aceprometazine	DAP001075
TTDS00086	Antagonist	Buclizine	DAP001076
TTDS00086	Antagonist	Trimeprazine	DAP001077
TTDS00086	Antagonist	Mequitazine	DAP001078
TTDS00086	Antagonist	Azatadine	DAP001079
TTDS00086	Antagonist	Chlophedianol	DAP001080
TTDS00086	Antagonist	(S)-(+)-Dimethindene maleate	DAP001340
TTDS00086	Antagonist	Acrivastine	DAP001343
TTDS00086	Antagonist	Antazoline	DAP001347
TTDS00086	Antagonist	Antazoline hydrochloride	DAP001365
TTDS00086	Antagonist	Dimethindene	DAP001366
TTDS00086	Antagonist	Antazoline phosphate	DAP001373
TTDS00086	Antagonist	Dimethindene maleate	DAP001378
TTDS00086	Antagonist	Levocetirizine dihydrochloride	DAP001397
TTDS00086	Antagonist	Mepyramine	DAP001399
TTDS00086	Antagonist	Mepyramine maleate	DAP001400
TTDS00086	Antagonist	Mizolastine	DAP001403
TTDS00086	Antagonist	Oxatomide	DAP001414
TTDS00086	Antagonist	Tranilast	DAP001531
TTDS00086	Antagonist	Bepotastine besilate	DCL000719
TTDS00086	Antagonist	Alcaftadine	DAP001553
TTDS00086	Agonist	Ergotidine	DAP001379
TTDS00086	Drug(s)	GSK835726	DCL000393	Allergic rhinitis	Suspended in Phase II in GSK 2009 Report
TTDS00086	Drug(s)	GSK1004723	DCL000399	Allergic rhinitis	Suspended in Phase II in GSK 2009 Report
TTDS00086	Drug(s)	Carebastine	DCL000738	Ocular allergy	Phase III
TTDS00086	Antagonist	GSK835726	DCL000393
TTDS00086	Antagonist	GSK1004723	DCL000399
TTDS00086	Antagonist	Carebastine	DCL000738
TTDS00086	Multitarget	GSK835726	DCL000393
TTDS00086	Multitarget	GSK1004723	DCL000399
TTDS00086	Agonist	8R-Lisuride	DNC000112
TTDS00086	Antagonist	Hydroxyclemastine	DNC000753
TTDS00086	Antagonist	Pyrilamine	DNC001174
TTDS00086	Antagonist	Pyrilamine Maleate	DNC001175
TTDS00086	Agonist	S-(-)-Lisuride	DNC001251
TTDS00086	Antagonist	Sch 37370	DNC001304
TTDS00086	Inhibitor	OCTOCLOTHEPIN	DNC004869
TTDS00086	Inhibitor	N-hydroxycarbamate derivative	DNC004871
TTDS00086	Inhibitor	N-hydroxycarbamate derivative	DNC004872
TTDS00086	Inhibitor	N-hydroxycarbamate derivative	DNC004873
TTDS00086	Inhibitor	N-hydroxycarbamate derivative	DNC004874
TTDS00086	Inhibitor	N-hydroxycarbamate derivative	DNC004879
TTDS00086	Inhibitor	N-hydroxycarbamate derivative	DNC004880
TTDS00086	Inhibitor	ATC-0175	DNC004953
TTDS00086	Inhibitor	SCH-37370	DNC005869
TTDS00086	Inhibitor	RUPATADINE	DNC005871
TTDS00086	Inhibitor	MDL-28163	DNC005872
TTDS00086	Inhibitor	MDL-105212	DNC005873
TTDS00086	Inhibitor	R-226161	DNC007402
TTDS00086	Inhibitor	VUF-10148	DNC008438
TTDS00086	Inhibitor	9-(Aminomethyl)-9,10-dihydroanthracene	DNC008730
TTDS00086	Inhibitor	KF-A6	DNC009420
TTDS00086	Inhibitor	R-dimethindene	DNC009877
TTDS00086	Inhibitor	1-(4-p-Tolyl-butyl)-piperidine	DNC010155
TTDS00086	Inhibitor	diphenyl(piperidin-4-yl)methanol	DNC010157
TTDS00086	Inhibitor	9-(2-aminoethyl)-9,10-dihydroanthracene	DNC010209
TTDS00086	Inhibitor	2-(9,10-dihydroanthracen-9-yl)-N-methylethanamine	DNC010210
TTDS00086	Inhibitor	9-(2-aminopropyl)-9,10-dihydroanthracene	DNC010211
TTDS00086	Inhibitor	N,N-dimethyl-2,2-diphenylethanamine	DNC010213
TTDS00086	Inhibitor	N-methyl-3,3-diphenylpropan-1-amine	DNC010214
TTDS00086	Inhibitor	N,N-Dimethyl-3,3-diphenylpropan-1-amine	DNC010215
TTDS00086	Inhibitor	4,4-Diphenylbutan-1-amine	DNC010216
TTDS00086	Inhibitor	N-methyl-4,4-diphenylbutan-1-amine	DNC010217
TTDS00086	Inhibitor	N,N-dimethyl-4,4-diphenylbutan-1-amine	DNC010218
TTDS00086	Inhibitor	3,3-diphenylpropan-1-amine	DNC010219
TTDS00086	Inhibitor	DIMEBOLIN	DNC010278
TTDS00086	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	DNC011171
TTDS00086	Inhibitor	MIANSERIN HYDROCHLORIDE	DNC011946
TTDS00086	Inhibitor	9-Phenyl-2,3-dihydro-1H-indeno[2,1-c]pyridine	DNC012812
TTDS00086	Inhibitor	1-[(Furan-2(5H)-one)-4-methyl]-desloratadine	DNC014184
TTDS00086	Target Validation	TTDS00086
